Literature DB >> 20699622

Smoking cessation: an integral part of lung cancer treatment.

Janine K Cataldo1, Sarita Dubey, Jodi J Prochaska.   

Abstract

UNLABELLED: Lung cancer is the leading cause of cancer death in the US. About 50% of lung cancer patients are current smokers at the time of diagnosis and up to 83% continue to smoke after diagnosis. A recent study suggests that people who continue to smoke after a diagnosis of early-stage lung cancer almost double their risk of dying. Despite a growing body of evidence that continued smoking by patients after a lung cancer diagnosis is linked with less effective treatment and a poorer prognosis, the belief prevails that treating tobacco dependence is useless. With improved cancer treatments and survival rates, smoking cessation among lung cancer patients has become increasingly important. There is a pressing need to clarify the role of smoking cessation in the care of lung cancer patients.
OBJECTIVE: This paper will report on the benefits of smoking cessation for lung cancer patients and the elements of smoking cessation treatment, with consideration of tailoring to the needs of lung cancer patients.
RESULTS: Given the significant benefits of smoking cessation and that tobacco dependence remains a challenge for many lung cancer patients, cancer care providers need to offer full support and intensive treatment with a smoking cessation program that is tailored to lung cancer patients' specific needs.
CONCLUSION: A tobacco dependence treatment plan for lung cancer patients is provided. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20699622      PMCID: PMC2945268          DOI: 10.1159/000319937

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  81 in total

Review 1.  The role of nicotine in smoking-related cardiovascular disease.

Authors:  N L Benowitz
Journal:  Prev Med       Date:  1997 Jul-Aug       Impact factor: 4.018

2.  Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.

Authors:  Douglas E Jorenby; J Taylor Hays; Nancy A Rigotti; Salomon Azoulay; Eric J Watsky; Kathryn E Williams; Clare B Billing; Jason Gong; Karen R Reeves
Journal:  JAMA       Date:  2006-07-05       Impact factor: 56.272

Review 3.  The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline.

Authors:  J Foulds
Journal:  Int J Clin Pract       Date:  2006-05       Impact factor: 2.503

4.  Smoking and timing of cessation: impact on pulmonary complications after thoracotomy.

Authors:  Rafael Barrera; Weiji Shi; David Amar; Howard T Thaler; Natalie Gabovich; Manjit S Bains; Dorothy A White
Journal:  Chest       Date:  2005-06       Impact factor: 9.410

5.  Smoking cessation after diagnosis of lung cancer is associated with a beneficial effect on performance status.

Authors:  Sevin Baser; Vickie R Shannon; Georgie A Eapen; Carlos A Jimenez; Amir Onn; E Lin; Rodolfo C Morice
Journal:  Chest       Date:  2006-12       Impact factor: 9.410

6.  Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression.

Authors:  Lisa Sanderson Cox; Christi A Patten; Raymond S Niaura; Paul A Decker; Nancy Rigotti; David P L Sachs; A Sonia Buist; Richard D Hurt
Journal:  J Gen Intern Med       Date:  2004-08       Impact factor: 5.128

7.  Continued family smoking after lung cancer diagnosis: the patient's perspective.

Authors:  Joan L Bottorff; Carole A Robinson; Kelli M Sullivan; Michelle L Smith
Journal:  Oncol Nurs Forum       Date:  2009-05       Impact factor: 2.172

8.  Quality of life of long-term survivors of non-small-cell lung cancer.

Authors:  Linda Sarna; Geraldine Padilla; Carmack Holmes; Donald Tashkin; Mary Lynn Brecht; Lorraine Evangelista
Journal:  J Clin Oncol       Date:  2002-07-01       Impact factor: 44.544

9.  The risk of second primary tumors after resection of stage I nonsmall cell lung cancer.

Authors:  David Rice; Hyung-Woo Kim; Anita Sabichi; Scott Lippman; J Jack Lee; Brendell Williams; Ara Vaporciyan; W Roy Smythe; Stephen Swisher; Garrett Walsh; Joe B Putnam; Waun Ki Hong; Jack Roth
Journal:  Ann Thorac Surg       Date:  2003-10       Impact factor: 4.330

Review 10.  Nicotine replacement therapy for smoking cessation.

Authors:  L F Stead; R Perera; C Bullen; D Mant; T Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23
View more
  53 in total

1.  Interventions for smoking cessation in people diagnosed with lung cancer.

Authors:  Linmiao Zeng; Xiaolian Yu; Tingting Yu; Jianhong Xiao; Yushan Huang
Journal:  Cochrane Database Syst Rev       Date:  2019-06-07

Review 2.  Lung cancer staging: clinical and radiologic perspectives.

Authors:  Sophie Chheang; Kathleen Brown
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

3.  Evaluation of a Dedicated Tobacco Cessation Support Service for Thoracic Cancer Center Patients.

Authors:  Katharine A Amato; Mary E Reid; Heather M Ochs-Balcom; Gary A Giovino; Maansi Bansal-Travers; Graham W Warren; Martin C Mahoney; Andrew J Hyland
Journal:  J Public Health Manag Pract       Date:  2018 Sep/Oct

Review 4.  Sniffer dogs as part of a bimodal bionic research approach to develop a lung cancer screening.

Authors:  Enole Boedeker; Godehard Friedel; Thorsten Walles
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-02-17

Review 5.  Tobacco Cessation in Oncology Care.

Authors:  Emily G Kaiser; Judith J Prochaska; Matthew S Kendra
Journal:  Oncology       Date:  2018-06-19       Impact factor: 2.935

Review 6.  Nicotine-mediated cell proliferation and tumor progression in smoking-related cancers.

Authors:  Courtney Schaal; Srikumar P Chellappan
Journal:  Mol Cancer Res       Date:  2014-01-07       Impact factor: 5.852

7.  Disparities between blacks and whites in tobacco and lung cancer treatment.

Authors:  Elyse R Park; Sandra J Japuntich; Lara Traeger; Sheila Cannon; Hannah Pajolek
Journal:  Oncologist       Date:  2011-09-29

8.  Cigarette smoking impairs the response of EGFR-TKIs therapy in lung adenocarcinoma patients by promoting EGFR signaling and epithelial-mesenchymal transition.

Authors:  Ming Liu; Chenzhi Zhou; Jian Zheng
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

9.  Practice patterns and perceptions of thoracic oncology providers on tobacco use and cessation in cancer patients.

Authors:  Graham W Warren; James R Marshall; K Michael Cummings; Benjamin Toll; Ellen R Gritz; Alan Hutson; Seyedeh Dibaj; Roy Herbst; Carolyn Dresler
Journal:  J Thorac Oncol       Date:  2013-05       Impact factor: 15.609

10.  Does Quitting Smoking Make a Difference Among Newly Diagnosed Head and Neck Cancer Patients?

Authors:  Seung Hee Choi; Jeffrey E Terrell; Carol R Bradford; Tamer Ghanem; Matthew E Spector; Gregory T Wolf; Isaac M Lipkus; Sonia A Duffy
Journal:  Nicotine Tob Res       Date:  2016-08-18       Impact factor: 4.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.